What a CGM Actually Shows in People Without Diabetes

In people without diabetes, CGM data mostly shows a system doing what it's supposed to do: glucose rises after meals and returns to a narrow range, with variability that tracks diet, sleep, and body composition rather than dysfunction. Gray literature often frames glucose spikes in non-diabetic wearers as inherently harmful, but most spikes sit within normal physiology. What's less settled is whether any of the finer-grained metrics a CGM produces, like time in a tight range, actually predict anything about long-term health in someone whose glucose control is already normal.

The gap between what a graph looks like and what it means

Someone without diabetes who puts on a CGM for the first time usually expects one of two things: either a flat, boring line, or proof that some food they eat is secretly a problem. What they tend to get instead is a graph full of movement, a rise after breakfast, a dip before lunch, a spike after that afternoon coffee with something sweet, and no built-in way to know if any of it matters.

That gap is exactly where a lot of the anxiety around consumer CGM use lives. A spike on the screen looks like an event. Whether it's worth caring about is a separate question, and it's one the research has actually tried to answer directly.

What a normal day looks like on a CGM

For most of the day, between 70 and 140 mg/dL. In 153 healthy, non-obese volunteers aged 7 to 80 wearing a blinded Dexcom G6 for up to ten days, the median was 96 percent of the day in that range, about 30 minutes a day above 140 and about 15 minutes below 70. Average glucose was 98 to 99 mg/dL in every age group except those over 60, at 104 (Journal of Clinical Endocrinology and Metabolism, 2019).

An older, less selected group shows more time above 140 without anything being wrong. Among 560 Framingham Heart Study adults with normal blood sugar, average age 58.5, the share of the day in range was 87 percent, with roughly 3 hours a day above 140 and more than 15 minutes above 180. Adults with prediabetes in the same study spent 77.1 percent in range and those with diabetes 46.2 percent (Journal of Clinical Endocrinology and Metabolism, 2025 [funding listed from Dexcom]).

Meals produce the rises. In the healthy-volunteer cohort, glucose went from about 93 mg/dL before eating to an average peak near 130, about an hour and a half later (Journal of Diabetes Science and Technology, 2021 [conflict statement: an author has Dexcom research grants and sits on its advisory board]). There is still no agreed cut-off for when a healthy person's trace needs a doctor's attention: 18 CGM specialists reviewing the same reports agreed poorly on who should be followed up (Journal of Diabetes Science and Technology, 2026 [conflict statement: authors have received fees or research support from Dexcom and Abbott]). KnowYourPrime's CGM desk rates the 70 to 140 normal range as Established.

What the numbers on the screen are actually tracking

Once you get past whether a spike is dangerous, the more interesting question is what the moment-to-moment glucose curve is actually reflecting. In healthy adults, CGM data has been linked to what and how much people eat, not just whether they're at risk for disease. One study following healthy adults for a week found that the area under the glucose curve after meals, along with measures like relative amplitude and standard deviation, correlated with the glycemic load of what they'd eaten, meaning the device was picking up on meal composition, not malfunction.

That distinction matters, it reframes the CGM less as a diagnostic tool for someone without diabetes and more as a diet-monitoring instrument. A related study working from the same idea found that individualized glucose responses to identical foods, like the swing after eating a potato compared to grapes, could function as a kind of metabolic signature unique to each person, rather than a universal good or bad reading.

That's part of why wearing a CGM often shifts what people notice about their own eating and movement patterns, even when nothing about their underlying glucose control has changed. The device isn't diagnosing anything in this population. It's translating meals and activity into a visual line.

Where the evidence stops short

A large analysis of CGM data from thousands of people without diabetes or prediabetes found that spending more time in a tight glucose range was associated with lower HbA1c, lower glucose after an oral glucose tolerance test, lower carbohydrate intake, and higher protein intake, plus a link to predicted cardiovascular risk strong enough to offer moderate discrimination. But the same analysis was explicit that these were exploratory, non-predefined comparisons, and that it remains unclear whether CGM metrics in people with normal glucose control actually predict anything about long-term health outcomes.

That caveat cuts against the instinct to treat every CGM metric as equally meaningful. A separate systematic review and meta-analysis of CGM use in non-diabetic populations describes the evidence on glycemic control, weight, and behavior outcomes as still unclear, which limits how confidently any of this can be built into everyday practice.

Extreme bodies, extreme numbers

Not every non-diabetic CGM reading comes from someone going about an ordinary day. A case series following elite athletes wearing CGMs during record-setting endurance events, including a multi-day cycling relay and an extreme climbing-equivalent cycling challenge, recorded glucose patterns during physical stress most people never approach. It gives a sense of how wide the non-diabetic glucose range can stretch under extreme exertion.

On the other end, glycemic variability shows up differently around major physiological change. A study following patients with and without type 2 diabetes through gastric bypass surgery found that six months after the procedure, patients without diabetes had lower average interstitial glucose and a lower glucose management indicator than both a matched non-surgical control group and the patients with diabetes, while variability itself rose only in the group with diabetes. A non-diabetic CGM curve isn't one fixed shape. It moves with what the body is doing.

Common questions